The latest research study “Biobanking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global biobanking market size reached US$ 53.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 77.6 Billion by 2027, expanding at a CAGR of 6.18% during the forecast period (2022-2027).
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/biobanking-market/requestsample
Biobanking refers to the procedure of storing and analyzing information about human biospecimens, which are collected from people with a particular condition or healthy volunteers. Biobanks are of two types, namely, population-based and disease-oriented. These modern procedures involve the large-scale analysis of specific disease biomarkers, which include digital or biological materials with well-annotated clinical data. Biobanking provides a basis for improving personalized medical approaches wherein effective identification is crucial for diagnosis and prognosis. As a result, these procedures find extensive utilization in research, academic institutions, pharmaceutical companies, etc., to improve the understanding of health as well as various diseases.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Biobanking Market Trends and Drivers:
The inflating need to analyze pathogens, collect high-quality human biospecimens, and identify therapeutic targets, on account of the sudden outbreak of the COVID-19 pandemic, is primarily driving the biobanking market. Besides this, the elevating demand for regenerative medicine and personalized treatments and the growing geriatric population are further augmenting the market growth.
Apart from this, the escalating developments in proteomics, disease biology, bioenergy, genomics, metagenomics, environmental remediation, ad other allied fields are also catalyzing the global market. Moreover, the rising innovations of products and services for sharing insights and critical information to advance scientific understanding are acting as significant growth-inducing factors.
Furthermore, several health agencies across countries are investing in virtual biobank network models that offer faster results, sustainable solutions, electronic databases, etc., which is expected to bolster the biobanking market in the coming years.
Global Biobanking Market 2021-2026 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Brooks Automation Inc., Bay Biosciences LLC, Boca Biolistics, Ctibiotech, Cureline Inc., Firalis, Greiner Bio-One International GmbH, Hamilton Company, Merck KGaA, ProteoGenex Inc., Thermo Fisher Scientific Inc. and VWR Corporation (Avantor Inc.).
The report has segmented the market on the basis specimen type, biobank type, application and end user.
Breakup by Specimen Type:
- Blood Products
- Solid Tissue
- Cell Lines
- Nucleic Acid
Breakup by Biobank Type:
- Population-based Biobanks
- Disease-oriented Biobanks
Market Breakup by Application:
Breakup by End User:
- Academic Institutions
- Pharma and Biotech Companies
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/biobanking-market
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800